Haleon plc (HLN)
NYSE: HLN · Real-Time Price · USD
10.31
-0.29 (-2.74%)
At close: Mar 18, 2026, 4:00 PM EDT
10.30
-0.01 (-0.10%)
After-hours: Mar 18, 2026, 7:00 PM EDT
Haleon Market Cap
Haleon has a market cap or net worth of $45.92 billion as of March 18, 2026. Its market cap has decreased by -1.68% in one year.
Market Cap
45.92B
Enterprise Value
55.72B
1-Year Change
-1.68%
Ranking
Category
Stock Price
$10.31
Market Cap Chart
Since July 18, 2022, Haleon's market cap has increased from $34.14B to $45.92B, an increase of 34.50%. That is a compound annual growth rate of 8.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 46.95B | 4.50% |
| Dec 31, 2025 | 44.93B | 5.03% |
| Dec 31, 2024 | 42.77B | 13.06% |
| Dec 29, 2023 | 37.83B | 3.87% |
| Dec 30, 2022 | 36.42B | 6.67% |
| Jul 18, 2022 | 34.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Takeda Pharmaceutical Company | 56.96B |
| Zoetis | 49.54B |
| Teva Pharmaceutical Industries | 34.05B |
| United Therapeutics | 23.24B |
| Viatris | 15.82B |
| Neurocrine Biosciences | 13.12B |
| Regencell Bioscience Holdings | 13.04B |
| Elanco Animal Health | 12.34B |